Bernard Man Yung Cheung

Division of Clinical Pharmacology and Therapeutics, Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong, China; Institute of Cardiovascular Science and Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.

Read more

Articles

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes

Chris Wai Hang Lo, Yue Fei, Bernard Man Yung Cheung, et al

Published:

Citation: Cardiac Failure Review 2021;7:e04.

DOI:

https://doi.org/10.15420/cfr.2020.19
Network Meta-analysis to Determine the Optimal Level of Systolic Blood Pressure for Hypertensive Patients

Bernard Man Yung Cheung, Y Fei, MF Tsoi, et al

Citation: European Cardiology Review 2020;15:e24.

DOI:

https://doi.org/10.15420/ecr.2020.15.1.PO1
Blood Lead Level and Hypertension Risk in the United States National Health Nutrition and Examination Survey (NHANES) 1999–2016

Bernard Man Yung Cheung, MF Tsoi, KKW Lui, et al

Citation: European Cardiology Review 2020;15:e36.

DOI:

https://doi.org/10.15420/ecr.2020.15.1.PO13
Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis

Bernard Man Yung Cheung, Y Fei, MF Tsoi, et al

Citation: European Cardiology Review 2020;15:e40.

DOI:

https://doi.org/10.15420/ecr.2020.15.1.PO17